SONN — Sonnet Biotherapeutics Holdings Share News
0.000.00%
Last trade - 00:00- $26.33m
- $26.01m
- $0.02m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 10:09 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:48 AM
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
NASDAQ RESUMED AT 09:42 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
Brief: Sonnet Biotherapeutics Holdings Announces Stockholder Approval Of Proposed Business Combination With Hyperliquid Strategies
U.S. STOCKS ON THE MOVE-BILL Holdings, Jackson Financial, Wills Towers Watson
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Sonnet Biotherapeutics Holdings Inc expected to post a loss of 49 cents a share - Earnings Preview
Brief: Sonnet BioTherapeutics Expands Trial of SON-1010 with Atezolizumab in Advanced Ovarian Cancer
U.S. STOCKS ON THE MOVE-Tesla, General Motors, Chevron
U.S. STOCKS ON THE MOVE-Aerospace firms, Tesla, natgas companies
U.S. STOCKS ON THE MOVE-Boeing, Crypto stocks, Kraft Heinz
U.S. STOCKS ON THE MOVE-Boeing, Crypto stocks, Kraft Heinz
Brief: Sonnet Biotherapeutics, Inc. Announces $888 Million Business Combination To Launch A Hype Cryptocurrency Treasury Reserve Strategy